These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12169200)

  • 1. Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study.
    Brandão AB; Fuchs SC
    BMC Gastroenterol; 2002 Aug; 2():18. PubMed ID: 12169200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu, China.
    He Y; Zhang J; Zhong L; Chen X; Liu HM; Wan LK; Wang H; Li H; Tian L; Hu JL; Luo P; Wang L; Chen Y; Liu T; Liu SL; Lü WB
    J Med Virol; 2011 Apr; 83(4):616-21. PubMed ID: 21328375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and seroprevalence of hepatitis C virus antibody among blood donors in Lagos.
    Balogun TM; Akinsete I; Durosinmi MA
    Niger Postgrad Med J; 2012 Mar; 19(1):36-9. PubMed ID: 22430600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
    Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
    Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence and risk factors for hepatitis C virus infection among blood donors in Serbia: A multicentre study.
    Mitrovic N; Delic D; Markovic-Denic L; Jovicic M; Popovic N; Bojovic K; Simonovic Babic J; Svirtlih N
    Dig Liver Dis; 2015 Jul; 47(7):572-6. PubMed ID: 25882212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological, epidemiological and molecular aspects of hepatitis C virus infection in a population from Londrina, PR, Brazil, 2001-2002.
    Vogler IH; Nishiya A; Morimoto HK; Reiche EM; Bortoliero AL; Matsuo T; Sabino EC; Vaz AJ
    Rev Inst Med Trop Sao Paulo; 2004; 46(6):303-8. PubMed ID: 15654474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection.
    Guimarães T; Granato CF; Varella D; Ferraz ML; Castelo A; Kallás EG
    Braz J Infect Dis; 2001 Jun; 5(3):111-8. PubMed ID: 11506773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors.
    Thakral B; Marwaha N; Chawla YK; Saluja K; Sharma A; Sharma RR; Minz RW; Agnihotri SK
    Indian J Med Res; 2006 Oct; 124(4):431-8. PubMed ID: 17159264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005.
    Andrade AF; Oliveira-Silva M; Silva SG; Motta IJ; Bonvicino CR
    Mem Inst Oswaldo Cruz; 2006 Sep; 101(6):673-6. PubMed ID: 17072482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey.
    Nascimento MC; Mayaud P; Sabino EC; Torres KL; Franceschi S
    J Med Virol; 2008 Jan; 80(1):53-7. PubMed ID: 18041005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The problem of hepatitis C virus infection in blood donors. Clinico-epidemiological, virological and histological evaluation].
    Sookoian S; Castaño G; Castiglioni T; Pilar S; Viudez P; González J; Frider B
    Medicina (B Aires); 1997; 57(6):699-707. PubMed ID: 9674191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seroprevalence of anti-hepatitis C virus antibodies among blood donors, Brazil].
    Paltanin LF; Reiche EM
    Rev Saude Publica; 2002 Aug; 36(4):393-9. PubMed ID: 12364912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria.
    Halim NK; Ajayi OI
    East Afr Med J; 2000 Aug; 77(8):410-2. PubMed ID: 12862062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors--the role of parenteral and sexual transmission.
    Shev S; Hermodsson S; Lindholm A; Malm E; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(2):99-104. PubMed ID: 7544914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of hepatitis C antibodies in healthy blood donors--a prospective study.
    Bagga PK; Singh SP
    Indian J Pathol Microbiol; 2007 Apr; 50(2):429-32. PubMed ID: 17883101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study.
    Delage G; Infante-Rivard C; Chiavetta JA; Willems B; Pi D; Fast M
    Gastroenterology; 1999 Apr; 116(4):893-9. PubMed ID: 10092311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India.
    Jain A; Rana SS; Chakravarty P; Gupta RK; Murthy NS; Nath MC; Gururaja S; Chaturvedi N; Verma U; Kar P
    Eur J Epidemiol; 2003; 18(7):695-7. PubMed ID: 12952145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.